These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Update on the epidemiology and management of cryptococcal meningitis. Desalermos A, Kourkoumpetis TK, Mylonakis E. Expert Opin Pharmacother; 2012 Apr; 13(6):783-9. PubMed ID: 22424297 [Abstract] [Full Text] [Related]
26. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y. J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027 [Abstract] [Full Text] [Related]
28. In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs. Abdel-Salam HA. Mycoses; 2005 Sep; 48(5):327-32. PubMed ID: 16115103 [Abstract] [Full Text] [Related]
29. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure. Li M, Liu J, Deng X, Gan Q, Wang Y, Xu X, Jiang Y, Peng F. BMC Infect Dis; 2020 Nov 16; 20(1):844. PubMed ID: 33198666 [Abstract] [Full Text] [Related]
30. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP. Medicine (Baltimore); 2003 Sep 16; 82(5):309-21. PubMed ID: 14530780 [Abstract] [Full Text] [Related]
31. Ventriculitis due to Cryptococcus uniguttulatus. McCurdy LH, Morrow JD. South Med J; 2001 Jan 16; 94(1):65-6. PubMed ID: 11213945 [Abstract] [Full Text] [Related]
32. [Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province]. Lei Y, Xiao YL, He C, Zhang CY, Xie Y, Kang M. Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan 16; 46(1):82-6. PubMed ID: 25807801 [Abstract] [Full Text] [Related]
33. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans. Hai TP, Van AD, Ngan NTT, Nhat LTH, Lan NPH, Vinh Chau NV, Thwaites GE, Krysan D, Day JN. Mycoses; 2019 Sep 16; 62(9):818-825. PubMed ID: 31173410 [Abstract] [Full Text] [Related]
37. Antifungal therapy for treatment of cryptococcal meningitis. Yao Z, Liao W, Wen H. Chin Med J (Engl); 2000 Feb 16; 113(2):178-80. PubMed ID: 11775548 [Abstract] [Full Text] [Related]
38. Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. Almeida AM, Matsumoto MT, Baeza LC, de Oliveira E Silva RB, Kleiner AA, Melhem Mde S, Mendes Giannini MJ, Laboratory Group on Cryptococcosis. FEMS Yeast Res; 2007 Jan 16; 7(1):152-64. PubMed ID: 17311593 [Abstract] [Full Text] [Related]